VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
IDEXX Laboratories, Inc. vs Transurban Group
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
IDEXX Laboratories, Inc.
IDXX · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into IDEXX Laboratories, Inc.'s moat claims, evidence, and risks.
View IDXX analysisTransurban Group
TCL · Australian Securities Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Transurban Group's moat claims, evidence, and risks.
View TCL analysisComparison highlights
- Moat score gap: Transurban Group leads (91 / 100 vs 82 / 100 for IDEXX Laboratories, Inc.).
- Segment focus: IDEXX Laboratories, Inc. has 4 segments (91.7% in Companion Animal Group); Transurban Group has 4 segments (49.5% in Sydney toll roads).
- Primary market structure: Oligopoly vs Quasi-Monopoly. Pricing power: Strong vs Moderate.
- Moat breadth: IDEXX Laboratories, Inc. has 5 moat types across 3 domains; Transurban Group has 3 across 3.
Primary market context
IDEXX Laboratories, Inc.
Companion Animal Group
Veterinary diagnostics and practice management software for companion animals
Global
Veterinary practices, corporate veterinary groups, and reference laboratories
Diagnostics platform owner (in-clinic instruments + consumables) and reference lab/service provider; practice management software provider
91.7%
Transurban Group
Sydney toll roads
Urban toll-road concessions (Sydney)
Sydney, New South Wales, Australia
Motorists and commercial fleet operators
Concessionaire / operator and developer
49.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
IDEXX Laboratories, Inc. strengths
Transurban Group strengths
Segment mix
IDEXX Laboratories, Inc. segments
Full profile >Companion Animal Group
Oligopoly
Water Quality Products
Oligopoly
Livestock, Poultry and Dairy
Competitive
Other (OPTI Medical and out-licensing)
Competitive
Transurban Group segments
Full profile >Sydney toll roads
Quasi-Monopoly
Melbourne toll roads
Quasi-Monopoly
Brisbane toll roads
Quasi-Monopoly
North America managed lanes and concessions
Quasi-Monopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.